Association of GLP-1 Receptor Agonists and Hepatocellular Carcinoma Incidence and Hepatic Decompensation in Patients With Type 2 Diabetes
Author:
Funder
National Institute on Alcohol Abuse and Alcoholism
National Cancer Institute
American Cancer Society
Publisher
Elsevier BV
Reference62 articles.
1. Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States;Islami;CA Cancer J Clin,2018
2. Epidemiology of hepatocellular carcinoma;McGlynn;Hepatology,2021
3. The anti-inflammatory and immunological properties of GLP-1 receptor agonists;Bendotti;Pharmacol Res,2022
4. The glucagon-like peptide-1 (GLP-1) analogue semaglutide reduces alcohol drinking and modulates central GABA neurotransmission;Chuong;JCI Insight,2023
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Metabolic dysfunction-associated steatotic liver disease and its link to cancer;Metabolism;2024-11
2. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may reduce the risk of developing cancer-related lymphedema following axillary lymph node dissection (ALND);Frontiers in Pharmacology;2024-09-04
3. Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Steatotic Liver Disease in Patients With Type 2 Diabetes Mellitus: Growing Evidence But Not Yet There;Gastroenterology;2024-09
4. Association of Semaglutide With Tobacco Use Disorder in Patients With Type 2 Diabetes;Annals of Internal Medicine;2024-08
5. Letter to the Editor: New confounders emerging with new evidence regarding reduced HCC and improved survival;Hepatology;2024-06-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3